Loading...
Market
Total investment by Eli Lilly in Indiana center by end of 2027?
3
Resolution / Starting Odds
Less than $4.5 billion • 25%
$4.5 billion to $5 billion • 25%
$5 billion to $5.5 billion • 25%
More than $5.5 billion • 25%
Eli Lilly's official financial reports, local government economic reports, or news reports
Story
Eli Lilly to Invest $4.5 Billion in New Indiana Manufacturing Center, Creating 400 Jobs and Boosting Tirzepatide Production
Oct 2, 2024, 12:06 PM
Eli Lilly announced plans to invest $4.5 billion in a new advanced manufacturing and drug development center in Indiana. The facility, named the Lilly Medicine Foundry, aims to drive innovation in drug production and manufacture medicines for future clinical trials. Scheduled to open in late 2027, the project is expected to create 400 full-time jobs and increase Eli Lilly's U.S. capital commitment to $23 billion. The new center will be located in the LEAP Research and Innovation District and will combine research and manufacturing in a single location. The investment will also boost API production for Tirzepatide and other pipeline medicines.
View original story
Similar markets
Less than $25 billion • 25%
$25 billion to $30 billion • 25%
$30 billion to $35 billion • 25%
More than $35 billion • 25%
Yes • 50%
No • 50%
Job Creation • 25%
Increased Production Capacity • 25%
Improved Supply Chain Efficiency • 25%
Other • 25%
Pleasant Prairie • 25%
Greater Wisconsin Area • 25%
Midwest Region • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than $100 million • 25%
$100 million to $200 million • 25%
$200 million to $300 million • 25%
More than $300 million • 25%
Yes • 50%
No • 50%
